Smith Ewan, Collins Ian
Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey, SM2 5NG, London, UK.
Future Med Chem. 2015;7(2):159-83. doi: 10.4155/fmc.14.152.
Photoaffinity labeling (PAL) using a chemical probe to covalently bind its target in response to activation by light has become a frequently used tool in drug discovery for identifying new drug targets and molecular interactions, and for probing the location and structure of binding sites. Methods to identify the specific target proteins of hit molecules from phenotypic screens are highly valuable in early drug discovery. In this review, we summarize the principles of PAL including probe design and experimental techniques for in vitro and live cell investigations. We emphasize the need to optimize and validate probes and highlight examples of the successful application of PAL across multiple disease areas.
光亲和标记(PAL)利用化学探针在光激活后与其靶标共价结合,已成为药物研发中用于识别新药物靶标和分子相互作用、探测结合位点位置和结构的常用工具。从表型筛选中鉴定命中分子的特定靶标蛋白的方法在早期药物研发中具有很高的价值。在本综述中,我们总结了PAL的原理,包括用于体外和活细胞研究的探针设计和实验技术。我们强调优化和验证探针的必要性,并突出PAL在多个疾病领域成功应用的实例。